A model that mimics the blood brain barrier, has been developed by Dr Zaynah Maherally and his team at the University of Portsmouth, clearing a way for better, more efficient and reliable tests of drugs to treat brain diseases.
The brain is protected by the near-impermeable blood brain barrier, a fortress which protects the brain but which also prevents the treatment of brain diseases, including brain tumors. The new model is the result of slow painstaking research started in 2007.
“The blood brain barrier is strikingly complex and notoriously difficult for scientists to breach. Its role, to protect the brain, makes it difficult for most drugs to make their way into the brain to treat brain tumors,”
Dr Maherally said.
A common way medics currently gain access to the brain is by using a pump to deliver drugs into the brain using a catheter, bypassing the blood brain barrier.
“It is a dynamic structural, physiological and biochemical fortification that, in essence, protects the brain by providing multiple layers of armour, stopping molecules from entering the brain. It’s highly selective in what it allows past,” Dr Maherally said.
“In a person with a brain disease like a brain tumour, or other neurological conditions such as Parkinson’s disease, dementia or head injuries, the strikingly complex defence works against medics and scientists trying to deliver what could be life-saving or life-prolonging treatments.”
The researchers’ major goal was to develop a 3-D all-human reproducible and reliable model of the blood brain barrier using human cells in order to better simulate the human blood brain barrier for the study of diseases and treatments.
Many researchers use non-human animal cells to build blood brain barrier models with which to explore brain cancer and deliver drugs to the brain.
Animal models have been relied upon until now as there wasn’t a reliable alternative and accessing human tissue for research can be difficult.
Brain Disease Study Holy Grail
Professor Geoff Pilkington, head of the Brain Tumour Research Centre in the University’s School of Pharmacy and Biomedical Sciences, is delighted at the progress that’s been made in modelling the blood brain barrier, a holy grail in the study of brain diseases:
“This is the first real, 3-D, all-human blood brain barrier model and it’s hugely significant in our field.”
Research will now widen, he said, to better understand how cancers metastasize from breast and lung to the brain as well as evaluating nano-particle drug delivery and making opportunities to create temporary openings in the barrier to allow drugs to pass through into the brain.
Zaynah Maherally, Helen L. Fillmore, Sim Ling Tan, Suk Fei Tan, Samah A. Jassam, Friederike I. Quack, Kathryn E. Hatherell, and Geoffrey J. Pilkington
Real-time acquisition of transendothelial electrical resistance in an all-human, in vitro, 3-dimensional, blood–brain barrier model exemplifies tight-junction integrity
FASEB J fj.201700162R; published ahead of print September 7, 2017, doi:10.1096/fj.201700162R
Image: Samah Jassam